Galera Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Updates

NEXT STORY
BioNTech Announces Third Quarter 2020 Financial Results and Corporate Progress
PREV STORY
Global Electrosurgery Devices Markets, 2020-2026 – Focus on Generators, Instruments, Accessories, & Argon and Smoke Management Systems
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Novartis Kisqali® delivers consistently superior overall survival – MONALEESA-3 trial demonstrates more life for postmenopausal HR+/HER2- advanced breast cancer patients

author_avatar
NASDAQ Market News

Sanofi : FDA approves Sarclisa® (isatuximab-irfc) for patients with relapsed refractory multiple myeloma

author_avatar
NASDAQ Market News

Philips delivers Q3 sales of EUR 4.2 billion, with a 7.6% comparable sales decline due to headwinds; income from continuing operations increases to EUR 442 million, and Adjusted EBITA margin amounts to 12.3%

author_avatar
NASDAQ Market News